Nectar Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 35.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 22.43 Cr
as on 16-11-2024
- Company Age 29 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1,339.35 Cr
as on 16-11-2024
- Satisfied Charges ₹ 4,910.08 Cr
as on 16-11-2024
- Revenue -6.71%
(FY 2023)
- Profit -188.69%
(FY 2023)
- Ebitda -64.96%
(FY 2023)
- Net Worth -2.05%
(FY 2023)
- Total Assets -8.39%
(FY 2023)
About Nectar Life Sciences
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 532649 and on the National Stock Exchange(NSE) under NECLIFE.
The Corporate was formerly known as Surya Medicare Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 35.00 Cr and a paid-up capital of Rs 22.43 Cr.
The company currently has active open charges totaling ₹1,339.35 Cr. The company has closed loans amounting to ₹4,910.08 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Nectar Life Sciences Limited India are Sushil Kapoor as Cfo, Amit Chadah as Ceo, and Neha Vaishnav as Company Secretary. Sanjiv Goyal, Meena Verma, Rupinder Tewari, and Three other members serve as directors at the Company.
Industry
Company Details
- LocationPunjab, Punjab
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Nectar Life Sciences Limited offer?
Nectar Life Sciences Limited offers a wide range of products and services, including Pharma & Bioanalytical Services, Pharmaceutical Services, Rapid Test Kit, Anti Infective Drugs & Medicines, Antibiotic Injection, Apparel & Textile Machinery, Textile Finishing Machine, Pharma Ingredients & Raw Materials, Anti Infective API, Pharma Raw Material.
Who are the key members and board of directors at Nectar Life Sciences?
Executive Team (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sushil Kapoor  | CFO | 14-Nov-2022 | Current |
| Sanjiv Goyal | Managing Director | 27-Jun-1995 | Current |
| Amit Chadah | CEO | 30-Oct-2020 | Current |
| Neha Vaishnav | Company Secretary | 14-Feb-2023 | Current |
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Meena Verma | Nominee Director | 11-Feb-2019 | Current |
| Rupinder Tewari | Director | 11-Feb-2019 | Current |
| Kuldip Bhasin | Director | 21-Sep-2021 | Current |
| Indu Kaur | Director | 02-Aug-2022 | Current |
| Puneet Sud | Whole-Time Director | 24-Sep-2022 | Current |
Financial Performance and Corporate Structure Insights of Nectar Life Sciences.
Nectar Life Sciences Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 6.71% decrease. The company also saw a substantial fall in profitability, with a 188.69% decrease in profit. The company's net worth dipped by a decrease of 2.05%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nectar Life Sciences?
In 2023, Nectar Life Sciences had a promoter holding of 44.35% and a public holding of 55.65%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 27 Dec 2023 | ₹6.05 M | Open |
Hdfc Bank Limited Creation Date: 28 Jun 2022 | ₹2.00 M | Open |
Hdfc Bank Limited Creation Date: 01 Dec 2021 | ₹2.00 M | Open |
How Many Employees Work at Nectar Life Sciences?
Nectar Life Sciences has a workforce of 1611 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nectar Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nectar Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
